Please sign in to follow a disease.
WaterPik for your head? study tests scalp massager for flakes and hair loss
NCT ID NCT05319444
First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 1 time
Summary
This study tested a WaterPik-like device to massage and clean the scalp in people with dandruff, seborrheic dermatitis, or hair loss. Only 2 people took part before the study was stopped early. The goal was to see if the device could reduce flaking and redness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
2 people
The number who actually took part.
- Started
-
May 2022
- Finished
-
May 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants must qualify for one of the following scalp conditions based on clinical opinion of a board-certified dermatologist: healthy scalp, dandruff, seborrheic dermatitis, or hair loss disease * All Women of Child Bearing Potential must indicate use of two of the following contraceptive methods. The WaterPik device uses an ultrasonic technology which includes ultrasound. Unnecessary ultrasound is not recommended for pregnant women. * Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal) * Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable) * Intrauterine device (IUD) * Intraurerine hormone-releasing system (IUS) * Vasectomized partner * Sexual abstinence * Barrier method, such as a condom Exclusion Criteria: * Non-English speaking * Exclusion related to pregnancy, lactation, or plans to become pregnant over the course of the study (based on self-report from the participant) * Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dandruff are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria supplement tested against chemo hair loss
- Can a serum plus a red light cap regrow hair?
- Can scalp chemistry explain stubborn itching without dandruff?
- Can a new shampoo outsmart dandruff in Hijab-Wearing women?
- A daily capsule might turn back the clock on skin and hair aging
- Can a skin ointment calm two stubborn redness conditions?